Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |